New developments in the treatment of follicular lymphoma/ marginal zone lymphoma (according to the Congress of the American Society of Hematology – 2020)
Relevance. Follicular lymphoma (FL) and marginal zone lymphoma (MZL) are the most common variants of indolent non-Hodgkin lymphoma (iNHL). Despite the adequate choice of the first-line therapy, 10 15% of affected patients with iNHL develop refractory disease, and in most of the cases the relapse of...
Guardado en:
Autor principal: | Lali G. Babicheva |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8dadf9c8a662484d9d55757ce54ddedf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of obinutuzumab alone and in combination for follicular lymphoma
por: Sarraf Yazdy M, et al.
Publicado: (2017) -
First-line therapy of indolent non-Hodgkin’s lymphoma in routine clinical practice
por: Lali G. Babicheva, et al.
Publicado: (2020) -
Antibody Therapies for Large B-Cell Lymphoma
por: Novo M, et al.
Publicado: (2021) -
Follicular lymphoma
por: Lali G. Babicheva, et al.
Publicado: (2020) -
Linfoma marginal del bazo asociado a acidosis láctica tipo B: Caso clínico
por: Vega,Jorge, et al.
Publicado: (2012)